Evaluation of the anticoagulant effect in Teneligliptin in type 2 diabetic patients

Trial Profile

Evaluation of the anticoagulant effect in Teneligliptin in type 2 diabetic patients

Recruiting
Phase of Trial: Phase I

Latest Information Update: 17 May 2016

At a glance

  • Drugs Teneligliptin (Primary)
  • Indications Glucose intolerance; Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 24 Mar 2014 Status changed from not yet recruiting to recruiting University Hospital Medical Information Network - Japan.
    • 08 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top